Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -120,855 | -154,154 | -213,913 | -164,826 | -102,985 |
| Depreciation Amortization | 9,364 | 11,107 | 11,418 | 10,705 | 10,947 |
| Accounts receivable | 4,475 | 12,551 | -5,380 | 768 | -10,438 |
| Other Working Capital | -8,127 | -12,519 | -715 | 36,373 | -4,781 |
| Other Operating Activity | 34,952 | 14,790 | 29,189 | 440 | 23,575 |
| Operating Cash Flow | $-80,191 | $-128,225 | $-179,401 | $-116,540 | $-83,682 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 2,902 | -2,928 | -15,946 | -5,964 |
| Net Acquisitions | N/A | N/A | -20,000 | N/A | N/A |
| Purchase Sale Intangibles | -15,000 | -5,000 | N/A | -400 | -1,200 |
| Other Investing Activity | -15,000 | -5,005 | 0 | 56,460 | -1,200 |
| Investing Cash Flow | $-15,000 | $-2,103 | $-22,928 | $40,514 | $-7,164 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 28,000 | 5,000 | 7,000 | N/A |
| Debt Issued | 43,670 | 14,529 | 47,112 | N/A | 60,000 |
| Debt Repayment | -51,000 | -50,375 | N/A | -10,450 | -78,223 |
| Common Stock Issued | 22,225 | 24,800 | 6,723 | 9,679 | 46,479 |
| Common Stock Repurchased | N/A | N/A | -1,105 | N/A | -70 |
| Dividend Paid | -4,710 | -8,768 | -8,780 | -8,780 | -6,752 |
| Other Financing Activity | 60,456 | 24,553 | 26,369 | 151,545 | 150,976 |
| Financing Cash Flow | $70,641 | $32,739 | $75,319 | $148,994 | $172,410 |
| Beginning Cash Position | 83,365 | 180,954 | 307,964 | 234,996 | 153,432 |
| End Cash Position | 58,815 | 83,365 | 180,954 | 307,964 | 234,996 |
| Net Cash Flow | $-24,550 | $-97,589 | $-127,010 | $72,968 | $81,564 |
| Free Cash Flow | |||||
| Operating Cash Flow | -80,191 | -128,225 | -179,401 | -116,540 | -83,682 |
| Capital Expenditure | N/A | -3,098 | -3,055 | -15,946 | -5,964 |
| Free Cash Flow | -80,191 | -131,323 | -182,456 | -132,486 | -89,646 |